A detailed history of Taylor Financial Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Taylor Financial Group, Inc. holds 2,071 shares of ABT stock, worth $241,892. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,071
Previous 2,206 6.12%
Holding current value
$241,892
Previous $251 Million 14.17%
% of portfolio
0.17%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$100.73 - $112.44 $13,598 - $15,179
-135 Reduced 6.12%
2,071 $215 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $9,747 - $10,765
-89 Reduced 3.88%
2,206 $251 Million
Q4 2023

Sep 17, 2024

BUY
$90.19 - $110.4 $20,202 - $24,729
224 Added 10.82%
2,295 $253 Million
Q4 2023

Feb 16, 2024

BUY
$90.19 - $110.4 $206,986 - $253,368
2,295 New
2,295 $253 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Taylor Financial Group, Inc. Portfolio

Follow Taylor Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor Financial Group, Inc. with notifications on news.